Abstract
Depression is an important cause of disability worldwide. However, the etiology of depression is still not completely understood. More systemic studies such as those in psychoneuroimmunology (PNI) are needed to improve the current situations. PNI studies of depression in different groups of people may contribute to the development of personalized, systems, and dynamical medicine. In recent years, more and more evidences have revealed the robust connections among stress, depression, and inflammatory pathways. Inflammation has the essential role in these processes at various systems levels. At the cellular level, T lymphocytes are critical in the susceptibility or resilience to major depressive disorder. Studies about the potential biomarkers may be meaningful for understanding the PNI of depression and the immune-modulating mechanisms of antidepressants. Such biomarkers should include the systems-based networks such as the hypothalamic–pituitary–adrenal (HPA) axis-mediated interactions between the serotonin regulation pathway and the stress response pathway. The depression-associated inflammatory networks often have overlaps with physical disorders including asthma, rheumatoid arthritis, cardiovascular diseases, obesity, cancer, and neurodegenerative diseases. The identification of the systems-based biomarkers in depression is crucial not only for better diagnosis, but also for the translation of the PNI discoveries into better clinical interventions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Archer, J. A., Hutchison, I. L., Dorudi, S., Stansfeld, S. A., & Korszun, A. (2012). Interrelationship of depression, stress and inflammation in cancer patients: A preliminary study. Journal of Affective Disorders, 143, 39–46.
Barrera, I., & Spiegel, D. (2014). Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression. International Review of Psychiatry, 26, 31–43.
Cheng, Y., Pardo, M., de Souza Armini, R., Martinez, A., Mouhsine, H., Zagury, J.-F., et al. (2016). Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior. Brain, Behavior, and Immunity, 53, 207–222.
Christmas, D. M., Potokar, J., & Davies, S. J. (2011). A biological pathway linking inflammation and depression: Activation of indoleamine 2,3-dioxygenase. Neuropsychiatric Disease and Treatment, 7, 431–439.
Cohen, L., Cole, S. W., Sood, A. K., Prinsloo, S., Kirschbaum, C., Arevalo, J. M. G., et al. (2012). Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: Role of inflammatory signaling. PLoS One, 7, e42324.
Delany, F. M., Byrne, M. L., Whittle, S., Simmons, J. G., Olsson, C., Mundy, L. K., et al. (2016). Depression, immune function, and early adrenarche in children. Psychoneuroendocrinology, 63, 228–234.
Demirtaş, T., Utkan, T., Karson, A., Yazır, Y., Bayramgürler, D., & Gacar, N. (2014). The link between unpredictable chronic mild stress model for depression and vascular inflammation? Inflammation, 37, 1432–1438.
DPNI. (2016). The database of psychoneuroimmunology. Retrieved July 1, 2016, from http://pharmtao.com/health/psychoneuroimmunology-database/
Dwivedi, Y., & Zhang, H. (2016). Altered ERK1/2 signaling in the brain of learned helpless rats: Relevance in vulnerability to developing stress-induced depression. Neural Plasticity, 2016, 7383724.
Garza, J. C., Guo, M., Zhang, W., & Lu, X.-Y. (2012). Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signaling. Molecular Psychiatry, 17, 790–808.
Ge, J.-F., Qi, C.-C., & Zhou, J.-N. (2013). Imbalance of leptin pathway and hypothalamus synaptic plasticity markers are associated with stress-induced depression in rats. Behavioural Brain Research, 249, 38–43.
Han, T. J., Felger, J. C., Lee, A., Mister, D., Miller, A. H., & Torres, M. A. (2016). Association of childhood trauma with fatigue, depression, stress, and inflammation in breast cancer patients undergoing radiotherapy. Psychooncology, 25, 187–193.
Hauger, R. L., Risbrough, V., Oakley, R. H., Olivares-Reyes, J. A., & Dautzenberg, F. M. (2009). Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Annals of the New York Academy of Sciences, 1179, 120–143.
Hou, R., Tang, Z., & Baldwin, D. S. (2013). Potential neuroimmunological targets in the treatment of anxiety disorders. Modern Trends in Pharmacopsychiatry, 29, 67–84.
Jaremka, L. M., Lindgren, M. E., & Kiecolt-Glaser, J. K. (2013). Synergistic relationships among stress, depression, and troubled relationships: Insights from psychoneuroimmunology. Depression and Anxiety, 30, 288–296.
Kallaur, A. P., Lopes, J., Oliveira, S. R., Simão, A. N. C., Reiche, E. M. V., de Almeida, E. R. D., et al. (2016). Immune-inflammatory and oxidative and nitrosative stress biomarkers of depression symptoms in subjects with multiple sclerosis: Increased peripheral inflammation but less acute neuroinflammation. Molecular Neurobiology, 53, 5191–5202.
Leem, Y.-H., Yoon, S.-S., Kim, Y.-H., & Jo, S. A. (2014). Disrupted MEK/ERK signaling in the medial orbital cortex and dorsal endopiriform nuclei of the prefrontal cortex in a chronic restraint stress mouse model of depression. Neuroscience Letters, 580, 163–168.
Liu, W.-X., Wang, J., Xie, Z.-M., Xu, N., Zhang, G.-F., Jia, M., et al. (2016). Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression. Psychopharmacology, 233, 405–415.
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011). Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Progress in Neuropsychopharmacology & Biological Psychiatry, 35, 769–783.
Martin-Subero, M., Anderson, G., Kanchanatawan, B., Berk, M., & Maes, M. (2016). Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectrums, 21, 184–198.
Moreno-Ramos, O. A., Lattig, M. C., & González Barrios, A. F. (2013). Modeling of the hypothalamic-pituitary-adrenal axis-mediated interaction between the serotonin regulation pathway and the stress response using a Boolean approximation: A novel study of depression. Theoretical Biology and Medical Modelling, 10, 59.
Musazzi, L., Mallei, A., Tardito, D., Gruber, S. H. M., El Khoury, A., Racagni, G., et al. (2010). Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression. Journal of Psychiatric Research, 44, 511–520.
Nikkheslat, N., Zunszain, P. A., Horowitz, M. A., Barbosa, I. G., Parker, J. A., Myint, A.-M., et al. (2015). Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression. Brain, Behavior, and Immunity, 48, 8–18.
Noto, C., Rizzo, L. B., Mansur, R. B., McIntyre, R. S., Maes, M., & Brietzke, E. (2014). Targeting the inflammatory pathway as a therapeutic tool for major depression. Neuroimmunomodulation, 21, 131–139.
Slavich, G. M., & Irwin, M. R. (2014). From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. Psychological Bulletin, 140, 774–815.
Smith, H. R. (2015). Depression in cancer patients: Pathogenesis, implications and treatment (Review). Oncology Letters, 9, 1509–1514.
Souza-Teodoro, L. H., de Oliveira, C., Walters, K., & Carvalho, L. A. (2016). Higher serum dehydroepiandrosterone sulfate protects against the onset of depression in the elderly: Findings from the English Longitudinal Study of Aging (ELSA). Psychoneuroendocrinology, 64, 40–46.
Su, K.-P. (2015). Nutrition, psychoneuroimmunology and depression: The therapeutic implications of omega-3 fatty acids in interferon-α-induced depression. Biomedicine (Taipei), 5, 21.
Toben, C., & Baune, B. T. (2015). An act of balance between adaptive and maladaptive immunity in depression: A role for T lymphocytes. Journal of Neuroimmune Pharmacology, 10, 595–609.
Voinov, B., Richie, W. D., & Bailey, R. K. (2013). Depression and chronic diseases: It is time for a synergistic mental health and primary care approach. Primary Care Companion for CNS Disorders, 15.
Won, E., & Kim, Y.-K. (2016). Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression. Current Neuropharmacology, 14, 665–673.
Yan, Q. (2012). Translational implications of inflammatory biomarkers and cytokine networks in psychoneuroimmunology. Methods in Molecular Biology, 934, 105–120.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Yan, Q. (2016). Psychoneuroimmunology of Depression. In: Psychoneuroimmunology. Springer, Cham. https://doi.org/10.1007/978-3-319-45111-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-45111-4_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45109-1
Online ISBN: 978-3-319-45111-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)